Skip to main content

Growth in Geriatric Population to Accelerate Orthopedic Implants Market

Orthopedic Implants Market is expected to exhibit significant growth over the forecast period. The market was valued at approximately USD 6,374.86 Million in 2018 and is projected to register a 4.71% CAGR over the forecast period.
The orthopedic implant market has witnessed a tectonic surge over the past few years, mainly due to the rising number of replacement surgeries like hip, knee, shoulder, and other joint or bone. The increased incidences of orthopedic diseases and injuries and rapid growth in the aging population are some of the growth stimulants of the orthopedic implants market. Advancing technological innovations like robot-assisted surgical tools, extensive application of orthopedic implants in the treatment of orthopedic diseases, musculoskeletal, and injuries, coupled with the increased acceptance of implantable medical devices are likely to encourage the market growth.
Competitive Dashboard
The top players operating in the orthopedic implants market include,
  • Globus Medical Inc. (US)
  • Depuy Synthes Inc. (Johnson & Johnson) (US)
  • Smith & Nephew plc. (UK)
  • NuVasive Inc. (US)
  • Zimmer Biomet Holdings Inc.
  • Stryker Corporation (US)
  • Medtronic plc (Ireland)
  • Integra LifeSciences Holdings Corporation (US)
  • Wright Medical Group N.V. (Netherlands)
  • The Orthopedic Implant Company (US)
  • BioTek Instruments Inc. (US)
  • Aesculap Implant Systems (US)
  • Conmed Corporation (US)
  • Arthrocare Corporation (US)
  • and others.
The orthopedic implant can be referred as a medical device, which is surgically placed within the body of a patient in order to restore functioning of bone by replacing or reinforcing a damaged structure. These implants are either withdrawn from the body after getting the desired results or permanently incorporated within the body.
Global Orthopedic Implants Market: Segmental Analysis
The orthopedic implants market has been segmented on the basis of procedure, product type, device type, biomaterial, application, and end-user.
By product type, the orthopedic implants market is segmented into dental implants, spinal implants, reconstructive joint implants, trauma and craniomaxillofacial implants, orthobiologics, and others. Of these, the reconstructive joint implants segment is estimated to gain prominence due to the soaring prevalence of osteoarthritis and osteoporosis and huge investments by the industry players in R&D.
The procedure segment comprises minimally invasive surgery (MIS), open surgery, and others. Of these, the minimally invasive surgery is huge demand globally due to fewer chances of infection post-surgery and minimum pain during the surgery.
Based on the biomaterial, the market is segregated into polymer biomaterials, metallic biomaterials, ceramic biomaterials, and natural biomaterials. Of these, the metallic biomaterials segment will garner considerable share, mainly due to the cost-effectiveness of these products. Moreover, these materials offer efficacy of bone healing compared to other materials, which further increases their demand.
Considering the device type, the market is segmented into external fixation devices and internal fixation devices.
Based on the application, the market consists of spine fracture, neck fracture, shoulder replacement, hip replacement, and others.
The end users segment comprises home cares, orthopedic clinics, hospitals, and others. Of these, the hospital’s segment is predicted to gain prominence due to favorable reimbursement policies and the presence of advanced healthcare facilities in hospitals.
Browse Complete Premium Research Details along with TOC BRIF@ https://www.marketresearchfuture.com/reports/orthopedic-implant-market-838
Regional Frontiers
Geographically, the orthopedic implants market spans across Europe, America, Asia Pacific, and the Middle East & Africa.
Considering the global scenario, America is likely to dominate the orthopedic implants market, mainly due to the surging geriatric population count, which has triggered the number of patients suffering from osteoporosis and osteoarthritis. In this region, North America is predicted to command the largest share with a revenue share of 53.4% in 2015. The gradual shift towards the use of minimally invasive procedures is predicted to offer the market a thrust.
Europe acquires the second spot in the orthopedic implants market. The regional growth is credited to the rise in the aging population, coupled with soaring demand for orthopedic devices and implants in the treatment of spinal cord disorders. The increased number of patients with bone-related diseases will further create promising opportunities for the sale of orthopedic implants in the market. This will encourage the market growth in the coming years.
The Asia Pacific is considered an emerging market due to the surging patient awareness levels associated with the commercial availability of orthopedic implants. The recent boom in medical tourism and improving healthcare infrastructure has further created new growth opportunities for the market in the APAC. Countries like India, Brazil, and China will register the fastest growth rate due to rising buying power, growing the aging population, and well-developed healthcare infrastructure.
Intended Audience
  • Medical Device Companies
  • Pharmaceutical Companies
  • Hospitals and Clinics
  • Diagnostic Centers
  • Academic Institutes
  • Government Organizations
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
+1 646 845 9312

Comments

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...

Middle East And Africa Pediatric Healthcare Market Development Research with Forthcoming Opportunities and Challenges

  Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023 Paediatric Healthcare-Overview Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues. Avail a Free Sample@  https://www.marketresearchfuture.com/...